Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

for
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 0+

Code: NCT06295965

Recruiting

AnovaOS Network Powered Patient Registry

for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc

Sex: All

Age: 18+

Code: NCT05013944

Recruiting

xDRIVE for Florida-based Cancer Patients

for
Cancer, Neoplams, Refractory, Recurrence, Leukaemia, Lymphoma,
Location: Miami FL
Sponsor: First Ascent Biomedical Inc.

Sex: All

Age: 0+

Code: NCT07167381

Recruiting

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

for
Multiple Sclerosis, Pathologic Processes,
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 18 - 70+

Code: NCT07759115

Recruiting

HEME Home Transfusion Program

for
Leukemia, Myeloma, Myelodysplastic Syndromes,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06487247

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

for
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 4 - 69

Code: NCT04339777

Phase 2, Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

for
Neoplasms, Brain, Glioblastoma Multiforme,
Location: Birmingham AL, St Louis MO, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 3 - 22

Code: NCT03911388

Phase 1, Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Brewer ME, Boston MA, Providence RI, West Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting
New

Three Times Weekly Symptom Screening for Children With Cancer

for
Cancer, Relapsed Cancer
Location: Toronto
Sponsor: The Hospital for Sick Children

Sex: All

Age: 2 - 18

Code: NCT04275102

Recruiting
New

Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on Tumors

for
Advanced Solid Tumors
Location: Huntersville NC
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07863024

Phase 1, Phase 2, Recruiting
New

A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors

for
Locally Advanced /Metastatic Solid Tumors,
Location: Houston TX
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07940881

Phase 1, Recruiting
New

Medically Tailored Meals to Improve Cancer Outcomes

for
Cancer, Healthy Eating
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07924241

Recruiting
New

Improving Care Delivery for Patients With Mental Illness and Cancer Across a Cancer Center Network

for
Cancer, Serious Mental Illness
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07707362

Recruiting
New

Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)

for
Post-transplant Lymphoproliferative Disorder
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07573436

Phase 1, Phase 2, Recruiting
New

Personalize My Treatment (PMT) Registry

for
Cancer
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18+

Code: NCT02355171

Recruiting
New

A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)

for
Malignant Neoplam, Advanced Solid Tumors
Location: Belleville NJ, East Brunswick NJ, Toronto, Maumee OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07793942

Phase 2, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial